Through ViroPharma's Named Patient Programme, healthcare professionals can prescribe certain investigational and pre-approval ViroPharma products to individual patients until the time that approval is launched in their local markets. Such products can be administered to individual patients who are suffering from serious illnesses and have no other therapeutic options. Eligible patients need a prescription from a physician and individual reimbursement secured.
Our partners IDIS and Clinigen Group PLC manage the Named Patient Programs on ViroPharma’s behalf. They also support physicians throughout the process.
For information on products please click here.
You are now leaving the ViroPharmaNPP.com
website, a website provided by Shire.